United Arab Emirates
Immediate Past President of Emirates Society of Cardiology, currently General Secretary Emirates Cardiac Society and Vice President of Gulf Intervention Society. Fellow of royal college of physicians UK, fellow American college of physician, fellow European society of cardiology, fellow of American college of cardiology, fellow American society of cardiac intervention and fellow of American heart association. Areas of Special Interest: Heart failure, Coronary artery disease, Dyslipidaemia, Hypertension, Arrhythmias, Cardiac intervention, Cardiac imaging, Screening for cardiac disease in sport players, Cardiovascular disease in pregnancy
Professor Shehab is a Chief editor of Emirates medical Journal and also service as editor in many other regional and international journals. Professor has published 152 paper in Medline
Abdulmajeed Al Zubaidi
United Arab Emirates
Dr. Abdulmajeed Al Zubaidi is a consultant Interventional Cardiologist at SKMC and is currently occupying the position of Chief Medical Officer in Sheikh Khalifa Medical City since 2012. Dr. Al Zubaidi manages acute and chronically ill cardiac patients as part of his routine daily practice and has particular expertise in all aspects of Cardiac well-being. He is a fellow of the Royal college of physicians (Canada). Fellow of the American college of Cardiology. Member of the American college of physicians. Member of the American heart association, Member of the society of cardiac CT and Member of the Society of Cardiac Angiography and Intervention.
Consultant none invasive cardiologist at IMC hospital JEDDAH
Head of echo section at IMC
MRCP(UK), FRCP (Edinburgh), American Board of Echo (NBE), American Board of CT coronary angio
Arab Board of cardiology
Saudi fellowship of cardiology
Master of cardiology Alexandria university
United States of America
Alexandra J. Lansky, MD, is Professor of Medicine in the section of Cardiology at the Yale School of Medicine and a practicing cardiologist at Yale-New Haven Hospital, in New Haven, CT. Dr. Lansky joined Yale in 2010 as Director of the Yale Heart and Vascular Clinical Research Program and the Cardiovascular Research Center (YCRC), which specializes in the conduct of national and international cardiovascular clinical trials with specific expertise in the evaluation of interventional devices. She most recently received a dual appointment as Chair of Cardiovascular Research at Queen Mary University in London as part of the Yale and London based Barts Heart Center transatlantic research collaboration.
Medical study in Paris and Marseille France
Head of the cathlab of Marseille Marignane France
Member of Euro CTO Club since 2011 and now member of the Board
Proctor for Bridgepoint system Dissection and reentry
CTO proctor for Abbott and Biosensor
Dr Ali Oto is a fellow of the European Society of Cardiology (ESC), the American College of Cardiology and Heart Rhythm Society. He has served on the Board and Committees of the several International Medical societies and organizations, including ESC (as a Board Member and Vice President), the International Society for Holter and Noninvasive Electrocardiology (Past President), and the North American Society of Pacing and Electrophysiology (Heart Rhythm Society), ACC and AHA and currently serving on the Global AF Alliance Board of Trustees. Dr Oto is a founding member and Past President of the Mediterranean Association of Cardiology and Cardiac Surgery (MACCS). Currently he is the Vice President of the Heart and Health Foundation of Turkey. He has served as a Steering Committee member for the Union Européenne des Médecins Spécialisés-Cardiology Section and currently he is the Vice President. Dr. Oto has also been honored as the President of the Turkish Society of Cardiology for two consecutive terms. He is a recipient of the MACCS Excellence in Cardiology award, the Professor İhsan Doğramacı High Honor Award, and also is an honorary member of the San Marino Society of Cardiology and honorary Professor of Belgrade University Medical Faculty. He has edited 25 books and he is the Author of more than 300 scientific papers. Currently he is the Chairman, Department of Cardiology in MHG, Memorial Ankara Hospital.
Ali Toure Ibrahim
Professeur Titulaire De Cardiologie
Diplome De Medecine Tropicale
Doyen Honoraire De La Faculte Des Sciences De La Sante
Chef Du Departement De Medecine Et Specialites Medicales
Universite Abdou Moumouni
Cardiologist and PhD Fellow at University Hospital of Brussels, Belgium, EACVI HIT Committee Member.
A Consultant Interventional Cardiologist at the Bristol Heart Institute, University Hospitals Bristol. His main interests are mechanisms and improvement of therapy in acute myocardial infarction and improving the treatment of transcatheter aortic valve implantations.
He is currently the Secretary of the European Association of Percutaneous Cardiovascular Interventions, a Co-Director of Euro-PCR, and Course director of Gulf-PCR.
Professor of Cardiology HEGP
Professor cardiology hôpital Georges Pompidou, Founder ARTERIAL REMODELLING TECHNOLOGIES
Medical School In Paris
Post Doc Cleveland Clinic
Past President Esc Wg Of Interventional Cardiology Esc Cofounder Eapci
Research Inserm Director For 13 Years
Head Interventional Cardiology Hegp
Founder 2 Startups : Art (Bioresorbable Stent Ce Marquage 2015) Scarcell Therapeutics (Cell Therapy In Regenerative Medicine)
Interventional cardiologist, ICPS, Massy, France
Antonio Carlos Palandri Chagas, M.D., Ph.D., F.A.C.C., F.E.S.C. is Full Professor of Medicine and Chief of Cardiology Division at Medical School of ABC and Coordinator of the Laboratory of Myocardial Ischemia at the University of São Paulo Heart Institute, São Paulo, Brazil.
He received his medical degree from the Medical School of ABC, in 1977. His internship was in internal medicine at the Federal University of São Paulo, and his specialist degree in cardiology was obtained at the University of São Paulo. In the early 1980s, he worked in the cardiovascular research laboratory at the Heart Institute of Medical School of the University of S. Paulo where he also presented a PhD thesis on myocardial ischemia. On completion of his PhD, he spent two years of post-doctoral study at the Cardiovascular Research Institute, University of California at San Francisco, USA.
- Attending Cardiologist, Medical Stamford Hospital, Stamford, CT, USA
- Visiting Assistant Professor of Medicine, Columbia University Hospital, New York, USA
- Primary Hemodynamics and Interventional Cardiology, San Raffaele Hospital, Milan
- Director of Catheterization Laboratory, Columbus Hospital, Milan
Responsible of the Electrophysiology and Cardiac stimulation Lab of the Cardiology department at “Spedali Civili di Brescia”
Dr Antonis Pantazis is a leading expert in inherited heart muscle conditions (Cardiomyopathies) with a wealth of experience in his speciality. He is a Consultant Cardiologist at the Royal Brompton and Harefield Hospitals in London and Clinical Lead for the Cardiomyopathy Service.
As part of these clinical activities, he is leading a state of the art interventional programme for the management of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy.
He also has a special interest in heart conditions in young athletes, where the major concern is sudden death or premature cardiac complications.
Dr Pantazis is the Chairman-elect of the nucleus of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
Dr Pantazis clinical research is focused on the clinical phenotype of cardiomyopathies, such as Hypertrophic Cardiomyopathy, Arrhythmogenic Cardiomyopathy (or Arrhythmogenic Right Ventricular Cardiomyopathy), Dilated Cardiomyopathy and Non-Compaction Cardiomyopathy, their genetic causes and the use of cardiac imaging for the clinical evaluation of the diseases. A number of research projects have been funded by National and European Grants. Institutional research endeavours and International collaborations have produced a number of highly valued scientific publications on peer-reviewed journals.
Dr Pantazis is also the Head of the Echocardiography Department at the North Middlesex University Hospital in London.
Arif Al Nooryani
United Arab Emirates
Consultant Interventional Cardiologist
Chief Executive Officer & Head of Cardiac Centre at Al Qassimi Hospital Sharjah
Dr. Al Nooryani is Consultant Interventional Cardiologist and Chief Executive Office & Head of Cardiology at Al Qassimi Hospital Sharjah, UAE. Dr. Al Nooryani is graduate of the College of Medicine and Medical Sciences (ULM-Germany). He is German Board certified in Internal Medicine and Cardiology.
Dr. Al Nooryani is an expert interventional cardiologist with a large experience in coronary stenting, peripheral vascular interventions and treatment of structural heart disease including TAVI and Mitral Interventions. He has established and structured the Invasive Cardiology Unit where more than 15000 heart patients have undergone Various Invasive Procedures including Diagnostic coronary angiograms, a wide range of complex Percutaneous coronary interventions. Awarded with Sheikh Hamdan Excellence Award for Medical Service (2011-2012) and Pride of Nation, UAE (2012).His goal is to develop new treatment techniques and be involved in international researches as well of further skills development including the healthcare administration part.
Athanasios J. Manolis
Director of Cardiology Department, Asklepeion Hospital, Athens, Greece
Adj. Professor of Medicine, Emory University, Atlanta, USA
Adj. Ass. Professor of Hypertension, Boston University, Boston, USA
Past-President and General Secretary of the Mediterranean Association of Cardiology and Cardiac Surgery, ex-member of the Council of the European Society of Hypertension, past Chairperson of the Working Group “Hypertension and Heart” of the European Society of Cardiology, and President of the Working Group “Hypertension Arrhythmias and Thrombosis” of the ESH.
He is Past President of the Hellenic Society of Hypertension, and was President of the Joint Meetings of ESH/ISH 2014 in Athens.
member of the American College of Cardiology, the American Heart Association, the Hypertension Council of the American Heart Association, the European Society of Hypertension, the International Society of Hypertension, the Mediterranean Association of Cardiology and Cardiac Surgery.
United States of America
Past President of the American College of Cardiology, Chief of the division of cardiology for Rhode Island and The Miriram hospitals, as well as The Warren Alpert Medical School of Brown University. She is a professor of medicine at the Alpert Medical School and has won numerous teaching awards at both Brown and Rhode Island Hospital. Poppas has served as interim chief since June 2017 and is also the director of the Lifespan Cardiovascular Institute, which includes Rhode Island, the Miriam and Newport hospitals and multiple offices around the state.
senior interventional cardiologist, San Raffaele Hospital and EMO-GVM Centro Cuore Columbus, Università Vita Salute, Milan, Italy
Executive member of the French Society of Cardiology.
Co-Director of Interventional cardiology graduated training, Paris University.
President of the Interventional cardiology group of the French Society of Cardiology.
Fellow of the Society for Cardiac Angiographies and Interventions (USA) Chief medical editor of EuroPCR online.
Board member of EAPCI (European association for percutaneous cardiovascular interventions) – co-chairman of communication committee.
Researcher Interventional Cardiologist Director, Cardiology, San Carlo Clinic
Bernhard Mumm has more than 30 years of entrepreneurial and technological experience as well as in-depth clinical expertise. Since 1983, he was pioneering MRI and CT 3D workstations. After entering TOMTEC in 1991, Bernhard served in various management positions, major shareholder and President & CTO. Since mid of 2017 he is a consultant for TOMTEC/Philips Healthcare in the field of Strategic Innovations.
Bernhard holds multiple patents, published in many publications and book chapters in the field of 3D Ultrasound and is regularly lecturing on international scientific congresses. He is an active member of international scientific committees. Bernhard holds a master’s degree in Computer Science and Cybernetics from the Technical University Munich/Germany.
United States of America
"Dr. Biykem Bozkurt is an advanced heart failure and cardiac transplantation specialist at Baylor College of Medicine (BCM), Houston TX, where she serves as the Associate Provost of Faculty Affairs and Senior Associate Dean of Faculty Development, Mary and Gordon Cain Chair in Cardiology and Professor of Medicine; Vice-Chair of Department of Medicine.
Dr. Bozkurt is the Immediate Past President of the Heart Failure Society of America. She has been identified as one of Web of Science’s World’s Highly Cited Researchers (top 1% Web of Science) in 2019. She serves as a Senior Associate Editor for Circulation; a Heart Failure Section Editor for the Journal of American College of Cardiology, and Co-Chair of the 20201 AHA/ACC Heart Failure Guidelines Writing Committee. She has served as the Heart Failure Council Chair of the American College of Cardiology and immediate Past Chair of the ACC/AHA Task Force for Clinical Data Standards.
Throughout her career, Dr. Bozkurt has been recognized for excellence in clinical care, education and leadership. She was the recipient of the National Veterans Affairs Secretary’s Hands and Heart Award for Recognition of Highest Standards in Patient Care in 2003, American College of Cardiology Proctor Harvey MD Young Teacher Award in 2005, BCM Barbara and Corbin J. Robertson, Jr. Presidential Award for Excellence in Education in 2014, BCM Master Clinician Lifetime Award in 2014, American College of Cardiology Gifted Educator Award in 2016, BCM Ben and Margaret Love Foundation Bobby Alford Presidential Award for Academic Clinical Professionalism in 2019 and BCM Distinguished Faculty Alumni Award in 2020. Additionally in 2018, she was selected among top 100 Turks Leading Medicine, and second highest ranking Turkish women scientist by Turkish Time Magazine.
Dr. Bozkurt actively participates in clinical and translational research; presents at national and international scientific sessions; teaches medical students, residents, fellows at bedside and in the classroom setting; mentors trainees and faculty locally and nationally."
Chair of HIT EACVI at EACVI
Carlo Di Mario
Professor Di Mario graduated in Medicine and specialised in Cardiology at the University of Padua in 1980. He then trained in interventional Cardiology completing the Fellowship at the University of Padua in 1984. He then moved to the Erasmus University of Rotterdam, Netherlands, where he completed a PhD thesis, moved in 1996 as research and clinical director for interventional cardiology at the University Vita-Salute of the San Raffaele Hospital in Milan, and was appointed Consultant Cardiologist at the Royal Brompton & Harefield NHS Foundation Trust in 2003. Between January 2003 and November 2016 Professor Di Mario worked as Professor of Clinical Cardiology, NHLI, Imperial College of Sciences, Medicine & Technology, and Consultant Cardiologist of the Royal Brompton & Harefield Foundation Trust, London. He was appointed in 2010 Senior Investigator of the National Institute of Health Research.
He became Full Professor of Cardiology at the University of Florence and Director of Structural Interventional Cardiology in the Careggi University Hospital, Florence, Italy in September 2016. He maintains an active clinical involvement in coronary angioplasty with special interest in treatment of chronic total occlusions, bifurcations, calcified lesions and diffuse disease. He is certified implanter for the Medtronic Evolut R and Pro, Edwards Sapien 3 and Ultra transcatheter aortic valves. He has 13 years of experience with MitraClips and started implants of CardioBand in 2017.
He served as Secretary of the Working Group on Interventional Cardiology of the European Society of Cardiology (ESC) and became President of the European Association of Percutaneous Cardiovascular Interventions between 2009 and 2011. Between 2012 and 2014 he served as Councillor of the European Society of Cardiology. He has been a member of the Writing Committee or a Reviewer of many ESC Guidelines including sudden death, percutaneous coronary angioplasty, STEMI, Myocardial Revascularisation, Stable Angina, Non-cardiac Surgery, Diabetes and Cardiac Diseases. He is first/last author or coauthor of many Expert Consensus documents (intravascular ultrasound, PCI in non surgical centres, optical coherence tomography, Rotablation, radial approach, renal denervation, intracoronary imaging guidance). He is current President, elected in September 2020, of the EuroCTO Club."
Medical Director of the Department of Thoracic- and Cardiovascular Surgery, Universit Hospital Tuebingen
Member Board of Directors of the German Cardiac Competence Center, Tuebingen at the University Hospital Tuebingen
Doctor Honoris causa of the Universidad de Santa Ana, El Salvador (UNASA)
Specialist in Cardiac Surgery (Board Certified) Specialist in Vascular Surgery (Board Certified)
Certificate Pediatric Cardiac Surgery (GSCTVS) Certificate Intensive Care in Cardiac Surgery
Dr. Naber started his career at the University Hospitals in Duesseldorf and Essen in Germany. He soon turned to interventional cardiology as his main field of interest and was part of the first TAVI implantation in Germany in 2004. After an interventional fellowship at Clinique Pasteur in France, he built up the Contilia Heart- and Vascular Centre in Essen, Germany. He soon became an active member of the PCR family and takes the responsibility as course director and course-co-director at several PCR activities. He is also member of the board of directors of the European Cardiovascular Research Center (CERC, Paris, France), and Chairman of the global Stent - Save a Life Initiative. In 2018 he left Germany to work in Zurich, Switzerland, and to intensify his cooperation with the group of Dr. Wijns at the University of Galway, Ireland. Currently, he is Director of the Medical Department I (Cardiology and Intensive Care) at the Klinikum Wilhelmshaven, Germany.
United States of America
Dr. White is Professor and Chairman of the Department of Medicine and Cardiology for the Ochsner Clinical School and Medical Director for Value-Based Care and System Chairman of Cardiovascular Diseases for the Ochsner Health System.
United States of America
Dipti Itchhaporia, MD, FACC, FESC is the Robert and Georgia Roth Chair of Cardiac Excellence and the medical director of disease management for Hoag Heart and Vascular Institute, in Newport Beach, California and Assistant Clinical Professor at the University of California, Irvine. She most recently served on the Board of Trustees for the American College of Cardiology (ACC) and was past Secretary and Chair of the Board of Governors for the ACC. She is also the Past President of the California state chapter of the ACC. She is presently the chair of the ACC’s nationwide Journal Club and is also on the editorial board for ACC’s extended learning (ACCEL) as well as the magazine Cardiology Today. Additionally, she is a member of the ACC’s Governance committee the Science and Quality committee, ACC 19 planning committee, ACC Middle East conference planning committee and co-chairs the Practice Administrators Workgroup.
University Hospital Bonn, Germany
Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CllC)University Hospital Bonn,Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine. He received his first degree in Medicine at the Rheinische Friedrich-WilhelmUniversity in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School. He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his postdoctoral lecturing qualification “Internal Medicine” from the Rheinische Friedrich-Wilhelm-University in Bonn. He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions. His research interest include drug eluting stents, distal protection devices, debulking devices, restenosis and in stent restenosis.
Prof. Ogola graduate with an M.B Ch.B from the University of Nairobi in 1979. He subsequently undertook residency at the the same institution leading to a masters in medicine in internal medicine in 1985. He was a visiting cardiology fellow at the Case Western University/University hospitals of Cleveland in 1989 to 1990. He was engaged as a lecturer at the department of Medicine, University of Nairobi in 1986, a department where he still serves as a professor of internal medicine and cardiology. He was the chairman of the department from 2000 to 2008. He served as the chairman of the Kenya cardiac society between 2000 and 2004. He has been an active member of the Pan African Society of Cardiology (PASCAR). He was elected vice president for the east African region in 2004 and served until 2017. He is currently the secretary general. He was elected in 2016 as the first governor of the African Chapter of the American College of Cardiology. His main research interests are hypertension, emerging cardiovascular risk factors in Africa and heart failure, fields in which he is extensively published. He is also a dedicated clinical teacher. He has acted as an external examiner in various institutions in the region.
United States of America
Dr. Emad Aziz is a Professor of Medicine and Section Chief of Cardiac Electrophysiology and Director of the Arrhythmia Institute at the Rutgers-NJMS University Hospital. Dr. Aziz is triple-certified by the American Osteopathic Board of Internal Medicine, the American Osteopathic Board of Cardiology, and Cardiac Electrophysiology.
Dr. Aziz completed his residency training in Internal Medicine and fellowships in Cardiology and Clinical Cardiac Electrophysiology at St. Luke’s-Roosevelt Hospital Center, a University Hospital of Columbia University College of Physicians and Surgeons, along with a fellowship in Advanced Heart Failure at Montefiore-Einstein Heart Institute. He is a fellow of the American College of Cardiology and a fellow of the Heart Rhythm Society.
Since coming to NJMS, there has been significant growth of the electrophysiology department with the latest innovations in rhythm management now being offered in both in- and outpatient settings. The procedure volume of the EP lab has increased by over 400% compared to the prior year. Dr. Aziz has introduced new procedures not previously offered in the state of NJ, including the Impulse Dynamic implantation and Wise-CRT device, through the international SOLVE-CRT trial, for advanced heart failure. University Hospital is also the first site in the state to use the newly approved MICRA AV leadless pacemaker.
University Hospital will also be one of the first institutions in the country to offer Respicardia Remedē device for central sleep apnea. In addition to the SOLVE-CRT trial, Rutgers is also enrolled in two other clinical trials: MARVEN study sponsored through NIH looking at risk factors associated with ventricular tachyarrhythmias in non-ischemic cardiomyopathy and the SAF-ILR trial studying the safety and cost-effectiveness of same-day loop recorder implantation vs. traditional telemetry observation for patients with unexplained syncope.
Dr. Aziz is actively involved in education and established an EP rotation for residents and an EP curriculum for fellows, including weekly ECG rounds as well as fostering multiple active research projects. He has extensively published more than 170 abstracts, over 100 manuscripts, and book chapters in peer-reviewed and professional journals. Dr. Aziz has future endeavors that include developing an ACGME accredited Electrophysiology fellowship program, comprehensive atrial fibrillation and advanced ventricular tachycardia management programs as well as introducing stereotaxis GENESIS system for advanced robotic ablations.
Dr. Fadi Bitar is Professor and Founding Director of the Children's Heart Center, and Ex-Associate Dean for External Medical Affairs at the American University of Beirut, Lebanon. He is the Co-Founder of the charitable organization, Brave Heart Fund. Dr. Bitar earns worldwide recognition as one of the leading Pediatric Cardiologists in Lebanon, the region and beyond, and has major contributions which include the successful establishment of educational and clinical programs resulting in improvements towards the care of thousands of children with CHD. Dr. Bitar introduced new modalities and techniques for the treatment of heart diseases, including procedures that were first of their kind in the world and reported worldwide discoveries regarding the genetic causes of CHD. Dr. Bitar is the recipient of several international awards, honors, medals, and research grants. He is the recipient of the Paul Harris distinguished model for his outstanding contributions to the community and the Humanitarian Recognition Award by “Rotary International Clubs and Gift of Life Project” in USA. He is also the recipient of the Diploma of the Knight of the honorary title "Name in Science" award and the medal ‘For Contribution to World Science’ presented by Academic Union of Oxford and the Club of Rectors of Europe.
Fakhr Al Ayoubi
Fakhr Zohair Al Ayoubi has a master degree in clinical pharmacy, & residency in clinical poisoning management. I work at the University hospital Cardiac Center as well as diabetic center, at the College of Medicine. My responsibility is critical care areas like CCU as well as the cardiology wards and cardiology ambulatory care clinics.
I was in charge of Drug Information and Poison Center at the King Khalid University Hospital (which is the oldest poison center in KSA) for a number of years before I joined the Cardiac Sciences Department.
I am Interested in clinical research and patient care. I teach the undergraduate pharmacy students as well as training Resident and Master degree students from Riyadh Taief , Jeddah and other Saudi Arabia regions. I participated in several gulf conference as well as meddle east to represent the Saudi experience in pharmacy field and am happy to chair my experience with you this time. I have been elected as the president of Saudi Cardio clinic pharmacist Group at the Saudi Heart Association
Professor of Cardiology Alexandria University
Consultant of Cardiology / Cardiac imaging King Abdullah Medical City Makkah
Dean of the Faculty of Medicine of the University of Lisbon (Lisbon, Portugal), and Full Professor of Cardiology, Head of the Cardiology Department and of the Heart and Vascular Department of Santa Maria University Hospital, CHLN E.P.E., President-Elect of the World Heart Federation (WHF) (2019-2020), National Coordinator of the Medical Schools Council (2018-2020) and President of the Executive Board of the Lisbon Academic Medical Centre (CAML) (2019-2021) and Director of Lisbon Cardiovascular Institute (ICVL) since 1999, Past-President of the Association for Research and Development of the Faculty of Medicine (AIDFM).
Filippo Crea was born in Cosenza, Italy on 19 September 1953. He graduated from Pisa Medical School with full honours in 1977 and passed the Postgraduate Boards in both Pulmonary and Cardiovascular Diseases, again with full honours, at Pisa Medical School in 1980 and 1983 respectively. During the whole of 1984 he was Research Fellow at the Division of Cardiology of the University of Florida. From 1985 to 1991 he was Honorary Clinical Assistant and then Senior Lecturer and Honorary Consultant at the Cardiovascular Research Unit of the Hammersmith Hospital in London. He returned to Italy upon his appointment as Chief of the Catheterization Laboratory at the Institute of Cardiology of the Catholic University in Rome. In 2000 he became Associate Professor of Cardiology and Chief of the Intensive and Sub-Intensive Care Unit. In 2001 he became Professor of Cardiology, Director of the Institute of Cardiology and Director of the Postgraduate School in Cardiology at the Catholic University in Rome. From October 2008 to January 2020 he was Director of the Department of Cardiovascular Sciences. Since February 2020 he is Director of the Cardiology Unit of Foundation Agostino Gemelli Hospital and Director of the University Department of Cardiovascular and Pneumological Sciences of the Catholic University of Rome.
He is Editor in Chief of the “European Heart Journal” (2020)
He is a Fellow of the American College of Cardiology and of the European Society of Cardiology
In 1992 he received from Professor Rita Levi Montalcini the Newburg Prize for his scientific contribution to the cardiovascular research.
In 2013 he received the Arrigo Recordati International Prize for lifetime achievement in researching the pivotal role of microcirculation in systemic and organ diseases.
His main fields of interest are coronary microcirculation, acute coronary syndromes and stem cells.
He is the author of more than 1000 publications in peer reviewed journals with an H-Index of 73.
2017-2018: fellowship in interventional cardiology Clinique Pasteur, Toulouse.
2018-2020: fellowship in interventional cardiology Universitary Hospital, Toulouse.
Since July 2020, Interventional cardiologist, La Rabta Hospital Tunis.
Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy
United States of America
Frank Ing is chief of the Division of Cardiology and co-director of the Heart Institute Center at the UC Davis Children’s Hospital, University of California, Davis in Sacramento, California.
He is involved with many national and international scientific societies. He is a fellow of the American College of Cardiology (FACC) and Master of Society of Cardiac Angiography and Interventions (MSCAI). He served as the chairman of the Congenital Heart Disease Council of the SCAI (2017-20) and is currently on the Board of Trustees for SCAI. He also serves on the steering committee of the Adult Congenital and Pediatric Cardiology (ACPC) section of the ACC. He is a founding member of the new PICS Society.
Dr. Ing’s clinical and research interests are primarily in the development of transcatheter techniques and cardiovascular devices to treat congenital/structural heart disease from the fetus to the elderly. In addition to clinical trials and outcome studies, he has conducted large animal studies and collaborated with industry in studies related to devices and therapeutic catheterizations.
Dr. Ing has trained numerous pediatric cardiology fellows and over 25 advanced pediatric interventional fellows over his career. To date, he has authored or co-authored 95 peer reviewed manuscripts, 10 book chapters and numerous abstracts. While providing ongoing career mentoring to medical students, residents and fellows each year, he has also hosted numerous international visiting professors and values collaboration among the international pediatric interventional community.
United Arab Emirates
Professor and consultant cardiologist at Al Moosa Medical Center and Emirates Hospital Dubai UAE Distinguished fellow of ISCU in the USA
President of ICC international college of Cardiology and ISCU Middle East Chapter of the international society of cardiovascular ultrasound USA
United States of America
Dr. Daniel is currently an Associate professor at Charles E. Schmidt College of Medicine, Florida Atlantic University, Florida. He is the Director of Cardiovascular Interventional Laboratories at Bethesda Memorial Hospital in Boynton Beach, Florida. Dr. Daniel completed his cardiology and interventional cardiology fellowship at the world-renowned Krannert Institute of Cardiology, Indiana University where he was elected chief Cardiology fellow. He was then selected to be the first fellow in Vascular and Endovascular medicine at the Washington Hospital Center, Washington, DC. Dr. Daniel directed busy clinical and training programs in Indianapolis, and Florida. His Areas of interest include advanced Trans-Catheter Valve Therapy and Endovascular Interventions.
Cardiovascular disease specialist at Bellevue Medical Center, Chair of the Cardiovascular Prevention Working Group at the Lebanese Society of Cardiology, Associate professor at the Lebanese university, Follow of the European Society of Cardiology and American College of Cardiology. He has been working as a clinician (Cardiologist) and academic in a different university hospitals from Europe, America, and Africa.
United States of America
Professor Emeritus, VCU Pauley Heart Center Virginia Commonwealth University
Richmond, Virginia USA Invasive cardiology for 40 years at VCU; Director of Cardiology for 18 years and Cath Lab for 38 years with over 300 publications. Grant funded for >30 years. Multiple Editorial Boards. Has served on Board of ACC, AHA and SCAI as well as Past SCAI President. Recognition include: Master of ACC and SCAI. VCU Presidential Medallion.
Interventional Cardiologist, Associate Professor at Aristotle University of Thessaloniki
Chief of the Cardiology Division at BUMC and founding director of the BITC-Bellevue International Training Center /American Heart Association. He is the Chairman of the Non Invasive working group at the Lebanese Society of Cardiology. He is a Co-Founder of the” Lebanese Chapter of the American College of Cardiology” and is currently Governor of this Chapter.
Giulia Vinco is a consultant cardiologist working at ‘Santa Maria del Carmine Hospital’ in Rovereto (University of Trento, Italy) and member of the EACVI HIT committee. She is also a PhD candidate in Clinical and Experimental Biomedical Sciences at the University of Verona, Italy. After graduation in Medicine and Surgery, she has attended the Cardiology Residency program at the University of Verona. She has spent 18 months as a research trainee at the McGill University Health Centre (Montreal, Canada), developing her research and clinical CMR skills under the supervision of Dr. Matthias Friedrich. She received the EACVI CMR Level 3 Certification in May 2017. She is an active member of the EACVI HIT community and twitter ambassador at EACVI congresses.
Professor Emeritus, University of Milano-Bicocca
President, ESH Foundation/Chairman, ESH Educational Board
President, Foundation "Ricerca e Innovazione su Ipertensione e Protezione Cardiovascolare"
Director, Center of Epidemiology and Clinical Trials, IRCCS Istituto Auxologico Italiano
Director, Hypertension Center, Istituto Clinico Universitario, Verano Brianza (Policlinico di Monza)
Chairman, Consulta of Italian Scientific Societies for Cardiovascular Prevention
Highly cited Researcher in Clinical Medicine (source Thomson Reuters 2015)
United States of America
Professor of Medicine at the Columbia University Medical Center, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital, and Co-Director of Medical Research and Education at the Cardiovascular Research Foundation in New York, NY.
United States of America
Gregory S. Thomas, MD, MPH is the Medical Director of Cardiovascular Program Development for the MemorialCare Health System in Southern California, USA. In this role, he serves as Clinical Professor and Director of Nuclear Cardiology Education at the University of California, Irvine. He is a Past President and a Master of the American Society of Nuclear Cardiology. With Adel Allam, MD, he leads the Horus research team that studies atherosclerosis in mummies and in cultures that alive today but who live an ancient lifestyle. In 2010, he received the Award of the 1st International Scientific Conference on Ancient Egyptian Culture from the Supreme Council of Antiquities and Cairo University. He has served as an investigator in >100 clinical trials with his research work reflected in 200 publications. He is co-author of the upcoming 6th edition of the textbook “Ellestad’s Stress Testing: Principles and Practice.”
Guy Heyndrickx graduated from the University of Ghent and trained as a cardiologist in Ghent and London at the National Heart Institute. In 1973 he joined the cardiovascular department of E Braunwald and S Vatner at the Harvard Medical School, Boston where his research was directed at describing for the first time the phenomenon of myocardial stunning. On his return to the University of Ghent he performed in 1980 the first PCI in Belgium. In 1984 he became co-director of the Cardio-vascular centre in Aalst where he became responsible of a program on interventional cardiology. In 1995 he was appointed part time Professor in cardiovascular physiology at the Louvain Medical School in Brussels. He is author of more than 200 publications in peer review journals and is fellow of the ESC, ACC
Head of Cardiology A Department at Fattouma Bourguiba University Hospital - Monastir, Tunisia
Chairman of the Pan African Course on Interventional Cardiology (PAFCIC) that is held annually since 2000 (www.pafcic.org)
Past President of the working group on interventional cardiology of the Tunisian Society of Cardiology and Cardiovascular Surgery
President of the Tunisian Heart Foundation
President of the African Heart Network
Hadi Abu Hantash
dr.abu -hantash was born in tulkarem in the west bank.he obtained his medical diploma from the university of Alexandria in Egypt. he then completed a masters degree in cardiovascular physiology at the university of Illinois in USA afterwhich he spent one year of cardiovascular research at Cleveland clinic in USA where he also completed his three year internal medicine training and went on to join the George Washington university hospitals for advanced cardiovascular fellowship.
he then joined an academic group based in Pittsburgh USA .
dr.abu-hantash is currently an assistant professor at the university of Jordan and is running his own busy private practice.
dr AbuHantash has been active teaching fellows and conducting cardiovascular research locally and globally.he sits on advisory boards for major international pharmaceuticals companies as well as interventional cardiovascular companies.he serves as a faculty in various cardiovascular meetings locally and regionally and internationally.
United States of America
Executive Vice-chair The Sanger Heart & Vascular Institute Atrium Health Clinical Professor Of Medicine Unc School Of Medicine Chair, Membership Committee Board Of Trustees American College Of Cardiology
President, Scottish Cardiac Society
Vice President, Royal College of Physicians and Surgeons of Glasgow
Consultant Interventional Cardiologist
Honorary Professor, Glasgow University, Institute of Cardiovascular & Medical Sciences
Regional & National Medicine-Director, Associate Medical Director
West of Scotland Heart & Lung Centre
Golden Jubilee National Hospital
Harriette Van Spall
Dr. Van Spall completed her Doctor of Medicine degree and postgraduate clinical training at the University of Toronto and a Master of Public Health degree at Harvard University. She is a full-time cardiologist, with a clinical focus in Heart Failure and Echocardiography at McMaster University. Funded by the Canadian Institutes of Health Research, she is a scientist who leads clinical trials in Heart Failure at the Population Health Research Institute. She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals, including JAMA, Lancet, Circulation, and Annals of Internal Medicine.
Hatem Soliman-Aboumarie is a Consultant in Cardiothoracic Intensive Care at Harefield Hospital, Royal Brompton and Harefield Hospitals Clinical Group, part of Guys and St Thomas NHS Foundation Trust, London, UK.
Trained in Critical Care Medicine and obtained an MSc in Critical Care Echocardiography from Alexandria University (Egypt). Trained in advanced Cardiothoracic Intensive Care and Mechanical Circulatory Support at the Royal Brompton and Harefield Hospitals.
Membership of the Royal College of Physicians (MRCP UK). Certification of special competence in Adult Echocardiography from the National Board of Echocardiography (USA). Diploma in Cardiology (London). European Diploma of Intensive Care Medicine (Brussels). Diploma in Clinical Education (Edinburgh).
Member of the Education, Scientific Initiatives, Web and Communication Committees and Deputy Chair of the Heart Imagers of Tomorrow Committee at the European Association of Cardiovascular Imaging (EACVI), European Society of Cardiology.
Associate Editor European Heart Journal - Case Reports, Editorial board member at the Journal of the American College of Cardiology - Cardiovascular Imaging and Frontiers Cardiovascular Imaging.
Elected Fellow of the Higher Education Academy of the UK, Fellow of the EACVI and Fellow of the American Society of Echocardiography.
Clinical and research interests: Medical Education, Critical Care Echocardiography, Lung Ultrasound and Mechanical Circulatory Support
National and international invited speaker, trainer and course director on Critical Care Echocardiography and Lung Ultrasound.
- Head of Department of Clinical Electrophysiology at Ordensklinikum Linz GmbH / Elisabethinen
- Mentor for Cardiac Electrophysiology and ablation techniques
- Academic Assoc. Professor of the University of Graz.
Dr. Horst Sievert is the Director of the CardioVascular Center Frankfurt, Sankt Katharinen, and the Department of Internal Medicine, Cardiology and Vascular Medicine of the Sankt Katharinen Hospital in Frankfurt, Germany. He is also an Associate Professor of Internal Medicine/Cardiology at the University of Frankfurt. He became director of the Department of Interventional Cardiology & Angiology of the Heart Center Rotenburg in 1990, senior consultant at the Bethanien Hospital in Frankfurt in 1993 and Director of the CardioVascular Center Frankfurt, Sankt Katharinen
Hossam El Gendi
Consultant invasive cardiologist and head of cardiac imaging department, Princess Alexandra Hospital, London UK
Royal College representative for the appointment of consultant Jobs
Special interest in advanced cardiac imaging."
After completing medical school with honors at Jordan University, Dr. Alhaddad moved to the USA where he completed residency in Internal Medicine followed by fellowship in Cardiovascular Diseases at the State University of New York at Stony Brook, New York. Next, he finished fellowship training in Vascular Medicine and Interventions at Tufts University School of Medicine, Boston-Massachusetts. At Johns Hopkins University, Baltimore-Maryland, he concluded a fellowship in Interventional Cardiology as well as a degree in the Business of Medicine. He is currently board certified by the American Board of Internal Medicine, Cardiovascular Diseases, Interventional Cardiology and Nuclear Cardiology. He maintains fellow rank at the American College of Physician and the American College of Cardiology.
His last appointment in the USA was the director of Cardiology Vascular Services and assistant professor of medicine at the Johns Hopkins University School of Medicine, Baltimore-Maryland. He is a recipient of many prestigious academic awards like the best teacher award from Albert Einstein College of Medicine and research awards from the American College of Physicians.
Dr. Alhaddad moved back to Jordan in 2004 and established the Jordan Cardiovascular Center and he is currently the director of cardiovascular department at Jordan Hospital. He established the transcatheter Aortic Valve Implantation (TAVI) program in Jordan in 2009, transcatheter Mitral valve Implantation (TMVI) in Jordan 2017 and Mitraclip program 2019. Dr. Alhaddad’s major research interests include acute coronary syndrome, left ventricular remodeling, complex percutaneous coronary interventions and peripheral vascular interventions. He participated in many national and international multicenter clinical studies and has published in many prestigious medical journals.
Associated Prof in Cardiology
Director of Interventional Cardiology -
SanGiovanmni Battista Hospital _ University of Torino
United States of America
Issam D. Moussa, MD, MBA
Medical Director | Heart & Vascular Institute
Director | Center for Trans Catheter Valve & Structural Heart Disease Therapies
Carle Health System
Professor of Medicine | Carle Illinois College of Medicine
Affiliate Faculty | Beckman Institute for Advanced Science and Technology
Jack C. Lewin
United States of America
Jack Lewin MD is Chairman, US National Coalition on Health Care (Washington DC), and President, Innovative Diabetes Treatment Studies LLC, a CV and diabetes clinical trial sponsor in NYC. He is former CEO of the American College of Cardiology, former President of the Cardiovascular Research Foundation (CRF/NYC), and is CEO of Lewin and Associates LLC, a health policy consulting firm in NYC.
Professor of Medicine, Head of I Dept. and Chair of Cardiology, Medical University of Lodz Poland.
690 papers, 110 chapters, Promoted 19 doctoral theses, 3 habilitations. Impact factor 613, >11500 citations, Hirsch index 40 Editorial Board Member: Cardiology, Echocardiography, Polish Journal of Cardiology, Cardiovascular Ultrasound.
Interventional Cardiologist in Rabat, Morocco
United States of America
Jeffrey W. Moses, M.D., John and Myrna Daniels Professor of Cardiology at Columbia University College of Physicians and Surgeons.
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 20,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the vast majority of procedures. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Heart Center in Roslyn, NY."
Prof.dr. Jeroen J. Bax, FESC (Leiden, Netherlands)
ESC Immediate Past-President (2018 – 2020), Jeroen Bax is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center, The Netherlands. His main interests include clinical cardiology, heart valve disease, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields. Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations, as well as serving on the editorial boards of many different journals."
Professor Cleland is a Cardiologist and Director of the Robertson Centre for Biostatistics, an internationally accredited Clinical Trials Unit offering a complete service, both to academia and industry, for the conduct of trials and registries in many therapeutic areas.
His main interest is heart failure, extending from its epidemiology & prevention to Phase II-IV trials and the development & implementation of guidelines. Particular current interests include the myocardial substrate, mechanisms of progression (eg:- congestion & inflammation), telemonitoring & theranostics.
He qualified from the University of Glasgow in 1977, completed training at St. Mary's & Hammersmith Hospitals (London). He was awarded a British Heart Foundation Senior Fellowship in 1994 and appointed as Professor of Cardiology at the University of Hull in 1999. In 2013, he moved to the National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College London. He was appointed as Director of the Robertson Centre in 2016.
He is Past-Chair of the ESC Working Group on HF and British Society for HF, founded the European Journal of HF and chairs the Academic Committee of the National HF Audit and the UK HF Investigators Research Network. He has >900 PubMed citations and is a Thomson Reuters Highly Cited Researcher. He was awarded an honorary Ph.D. (University of Hasselte, Belgium), Joy Edelman Medal (British Cardiovascular Society), William Stokes Medal (Irish Cardiac Society) and RT Hall lecture 2018 (ANZ Cardiac Society)"
Dr Byrne is the Clinical Director of Cardiovascular services at King's College Hospital. He completed his undergraduate medical training in Bristol and then continued general professional medical training in the South-East of England and London. A PhD in the was awarded in 2004 by the University of London; this examined the molecular mechanisms underlying left ventricular hypertrophy.
José A Mangione
President of the Latin American Society of Interventional Cardiology (SOLACI)
Professor of Medicine at the University of Valencia, Head of the Institute of Medicine of the Hospital Clínico of Valencia and of the Cardiovascular and Renal Research Group, INCLIVA. Past-President European Society of Hypertension. Scientific Director of the Research Institute INCLIVA (2009-2017).
"Dr. Grapsa is responsible for the valvular heart disease network and echocardiography.
Dr. Grapsa’s areas of research include valvular heart disease and the study of right heart remodelling. During her PhD research, Dr. Grapsa studied the right heart remodelling in idiopathic pulmonary arterial hypertension with echocardiography and cardiac magnetic resonance.
Dr. Grapsa has served as chair of the young community for multimodality imaging for the European Association of Cardiovascular Imaging and as a member of the European Society of Cardiology (ESC) education committee, leading the ESC clinical case gallery. She was responsible for ESC social media, since its birth and she has been a member of imaging and online education committees of the Heart Failure Association.
Prior to her role as JACC: Case Reports editor-in-chief, Dr. Grapsa served as an editorial consultant for JACC: Cardiovascular Imaging. She is a fellow of the ACC, the American Heart Association, the American Society of Echocardiography and the European Society of Cardiology."
United States of America
Clinical Assistant Professor Wayne State University
Director, Cardiac Catheterization Laboratory
Edith and Benson Ford Heart and Vascular Institute
Henry Ford Hospital, Henry Ford Health System
College of Medicine
Department of Cardiac Sciences
King Fahad Cardiac Center
King Saud University
- certified nuclear cardiologist.
-certified interventional cardiologist.
- Certified Cardiac CT imaging cardiologist.
-certified consultant internist.
-Vice Dean faculty of medicine AL-Imam Muhammed Ibn Saud university2015-2017
-board member of Saudi society of sport medicine
-member of Saudi registration committee in Saudi food and drug association
-member of the high committee of training and education in AL-Imam university.
-Head of nuclear cardiology Lab in PSHC, KFMC.2006-2009
-programme director of internal medicine residency programme SFH.2011-2012
-head of cath lab at security forces hospital.2009-2013
-Professor of cardiology ,ALIMAM Mohhammed Ibn Saud University.
-member of drug vigilance and surveillance committee in Saudi FDA.
-Moderator of Riyadh chapter of Saudi interventional cardiology society. 2006-2011
-chairman of continuous professional education committee in Saudi heart association. 2006-2012
-founder and chairman of imaging committee of Saudi heart association.2009-2013
-advisory board member of Saudi heart association.2007-2015
Khalid Bin Thani
Khalid Bin Thani, MD, MAS, FACC, FAHA, FESC, FACP, FICA, FSVM, FASA. Consultant Physician, Internal Medicine and Cardiovascular Medicine. Chairman, Department of Internal Medicine. Program Director, Internal Medicine Residency Program at Salmaniya Medical Complex, Ministry of Health, Manama. Clinical Senior Lecturer in Medicine, Medical University of Bahrain (MUB) - (RCSI-Bahrain), Manama, Kingdom of Bahrain.
President, Bahrain Cardiopulmonary Resuscitation Association, Manama, Kingdom of Bahrain. Dr Bin Thani has published multiple research papers in the field of cardiology in multiple peer-reviewed journals and has collaborated in several multi-center trials in the region. He has an interest in interventional cardiology, general and acute cardiovascular care, lipidology, and pulmonary hypertension field.
Consultant Adult Congenital Heart Disease & Pediatric Cardiology,interventional ACHD,Prince Sultan Cardiac Center,Riyadh , KSA
Khalid Tammam, MD, FSCAI
Consultant interventional cardiology and Director invasive department in international medical center, Jeddah, KSA since 2010
He completed general cardiology training in National Heart institute, Cairo - Egypt.
Completed Fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse. 2008-2009 as Award of EAPCI grant 2008.
He has received training of TRI and CTO for in South Korea and Japan 2004- 2005.
Master degree from saint Etienne University France, visiting research fellow for PhD in Tokai University Japan .
PhD Tokai Univeristry .
His main areas of interest are complex coronary interventions and chronic total occlusion.
He has been actively involved in many new technologies and devices in the field of interventional cardiology.
He is funder of IMC live CTO summit course in Jeddah, KSA since 2011.
United States of America
the Director of Peripheral Vascular Interventions at Emory University, Atlanta, USA. He treats patients with coronary artery, carotid artery, peripheral arteries and chronic venous disease. He is actively involved in clinical research and teaches nationally and internationally.
Dr Papadopoulos is a consultant cardiologist, head of Echocardiography lab, specialized in advanced cardiac echo techniques (TOE, 3D, Stress Echo, Speckle tracking). He is experienced in guiding structural heart diseases and transcatheter heart valves, especially MitraClip and PASCAL implantation. He is a fellow of the EACVI (FEACVI), member of the WG of valvulopathies and has an active role as a researcher in several trials (RESHAPE-HF2, EVOLUT-R FORWARD, INTREPID, POSE, SPACER Trial, CLASP, CLASP-P5). He has just completed his PhD on MitraClip and deformation imaging and has several pubmed publications.
ORCID ID: https://orcid.org/0000-0001-7356-2379
Google Scholar: Konstantinos Papadopoulos, MD, PhD, FESC, FEACVI
"Konstantinos Tsioufis is Professor of Cardiology and Director of the 1st Cardiological clinic of the Hippokration Hospital, National and Kapodistrian University of Athens, Greece. Prof Tsioufis works as an interventional Cardiologist as well as Hypertension Specialist in the 1st Department of Cardiology, University of Athens. He has special interest in cardiorenal disease, heart failure, sudden death and peripheral arterial disease. He was a post-doctoral fellow at the Veterans Affairs Medical Centre, Georgetown University Washington DC, USA.
Professor Tsioufis’s research focuses on the hypertensive disease, atherosclerotic cardiovascular disease and interventional Cardiology including novel interventional therapies of hypertension. He has been involved in many RCTs in hypertension, heart failure and cardiometabolic disorders. He has more than 400 publications in peer-reviewed Journals, H-index> 50, more than 11000 citations and more than 450 invited lectures at international meetings . Member of the Task Force for writing the 2018 joint ESC/ESH guidelines for Hypertension. Co-editor of the books ‘’interventional therapies of secondary and essential hypertension’’ and ‘’ ESH Manual of Hypertension, 5th edition, 2019’’ . He has contributed with more than 20 Chapters in Books. Member of the Editorial Board and Reviewer in many Cardiology and Hypertension Journals . Prof Tsioufis has served as President of European Society of Hypertension (ESH) (2017-19) and President of the Hellenic Society of Cardiology (2016-18)."
United Arab Emirates
Currently the Chair of Clinical Pathology at the Pathology & Laboratory Medicine Institute- at Cleveland Clinic Abu Dhabi. She completed her post-graduate training at the University of British Columbia- Canada and obtained the Canadian and American boards in Medical Biochemistry and Clinical Pathology respectively. She also obtained a Masters Degree in Health Care Administration (EMHCA) from Zayed University, UAE. previous employment was at British Columbia Children’s & Women’s Hospital in Vancouver- Canada, followed by Mafraq & SKMC hospitals in Abu-Dhabi. Her last appointment prior to joining CCAD was as a Chief Medical Officer of Pathology & Laboratory Medicine Services at SEHA and the Chair of Pathology & Laboratory Medicine Department at Sheikh Khalifa Medical City. Abu Dhabi, UAE. She is an active member of various scientific societies and has several publications to her credit in the field of laboratory medicine. Dr. Laila is a recipient of Dr. Arthur Bloomfield Award for Excellence in Medical Education as well as Sheikh Rashid Award for Scientific Outstanding.
Prof. Tokgözoğlu has served on the executive committee of the European Society of Atherosclerosis and is currently the President of the European Atherosclerosis Society. She also served as the president of the ‘Atherosclerosis and Vascular Biology Working Group of the European Society of Cardiology’ between 2008 and 2010. Prof. Tokgözoğlu has served on the board of the Prevention Association of the European Society of Cardiology between 2011-2016. She has been on the European Society of Cardiology Fellowship and Training Committee and the Education Committee. She was the President of the Turkish Society of Cardiology between 2014-2016 after serving on the executive committee for several years. Prof. Tokgözoğlu has been elected to the ‘Science Academy in Turkey’ in 2014. She is on the Editorial Board for European Heart Journal, Atherosclerosis, Anatolian Journal of Cardiology and Archives of the Turkish Society of Cardiology.
American Board and Canadian Fellowship certified in Internal Medicine and Cardiology Toronto 1986-1989
Previous Director of Cath Lab, and Director of Cardiology Fellowship Training Program KFSH and RC Riyadh, KSA 1990-1996
Medical director / The Cardiovascular Consultants Group clinics, Jeddah, KSA 1996 till now
Member of The Board of Directors, Saudi Heart Association 1992-2005
Member of The Scientific Committee of The Saudi Commission For Health Specialists for the Cardiovascular Fellowship Program in KSA From 31 January 2013 Till 31 December 2016
Senior Consultant Interventional Cardiologist, Assistant Professor, and Director of Saudi Cardiology Fellowship Training Program in King Abdulaziz University Hospital, Jeddah KSA, September 2011-May 2016"
United States of America
Dr. Shaw is a leading cardiovascular researcher whose major focus in the quality and effectiveness in the clinical diagnosis and imaging of ischemic heart disease. She has published >700 publications and presented >300 abstracts in major scientific meetings worldwide. She is ranked as one of the top 1% of clinical researchers with the most highly cited publications.
Dr. Saba joined St. George’s Hospital and University of London as a Consultant and Senior Lecturer in Cardiac Electrophysiology in 2010. He previously served as Assistant Professor at the University of Maryland School of Medicine, Baltimore, Maryland, USA, in the division of Cardiology and Cardiac Electrophysiology for four years. After receiving his medical degree from the Faculty of Medicine at Cairo University, Egypt, Dr. Saba completed a residency and obtained his M.Sc. in Cardiovascular Disease at Cairo University Hospitals. Subsequently, he completed his internship and residency in Internal Medicine at SUNY at Syracuse, New York, and The George Washington University Medical Center, Washington, DC, USA. He completed his fellowship in Cardiovascular Disease at the Ochsner Clinic Foundation, New Orleans, USA, where he was the recipient of the 2005 Charles B. Moore Research in Car diology Award, and subsequently a sub-fellowship in Clinical Cardiac Electrophysiology at Loyola University, Chicago, Illinois, USA. Dr. Saba is certified by the American Board of Internal Medicine in Internal medicine, Cardiovascular Disease and Cardiac Electrophysiology.
Dr Saba's research focuses on ventricular tachyarrhythmia mapping and ablation, with a special interest in efficient site of origin localization. is founding Chairman of the Annual London VT Symposium.
United States of America
Dr Ebeid is an Egyptian native who trained in General Pediatric Cardiology at the University of Miami, USA; and in Pediatric and Congenital Interventional Cardiology in the Cleveland Clinic Foundation; Dr. Ebeid is a tenured Professor of Pediatrics (Cardiology) and Director of Pediatric Catheterization Laboratory at the University of Mississippi Medical Center. He is recognized nationally and internationally as a pioneer in the field of catheter intervention for complex congenital heart disease; receiving referrals and awards from within and outside the United States. He has been invited to multiple countries to perform and teach catheter intervention procedures. Principal investigator for many devices. The first in his region to perform many cardiac interventions as VSD closure, percutaneous valve placement, use of large stents, covered stents, etc. Pioneered catheter closure of perimembranous VSDs; he has authored multiple papers and book chapters dedicated to catheter intervention techniques; He is recognized as an authority in transhepatic cardiac catheterization and intervention. He is an invited reviewer of many prominent medical journals, presented live interventions before national and international audiences. He authored or co-authored many medical papers enriching the field of Pediatric Catheter Interventions, in addition to multiple book chapters. He has been invited as a moderator, chairperson, speaker, and faculty in many prominent international cardiac conferences as well as director of prominent cath/congenital heart disease conferences and on the scientific committee of conferences/webinars, teaching advanced catheter procedures.
Professor Mamas Mamas is the Professor of Cardiology at Keele University and is the Clinical Director of the NIHR and MRC funded Centre for Prognosis Research at Keele University, and a consultant interventional cardiologist at the Royal Stoke Hospital. Professor Mamas qualified at the University of Oxford and trained at Oxford, Royal Brompton and Hammersmith Hospitals in London and undertook his interventional cardiology training in Manchester. Professor Mamas's research interest focus around the use of routinely collected electronic healthcare data to inform clinical outcomes (prognosis) of patients with cardiovascular disease.
Cardiologist with a specific interest in cardiac imaging (echocardiography, cardiac MRI and cardiac CT) working currently at the Monzino Cardiac Centre in Milan, Italy.
United States of America
Dr. Mark Sklansky is the Chief of Pediatric Cardiology and Professor of Pediatrics at the David Geffen School of Medicine at UCLA. He founded and serves as Medical Director of the UCLA Children’s Heart Center. He serves as Director of the UCLA Fetal Cardiology Program, and as Co-Director of the UCLA Congenital/Pediatric Heart Program.
Dr. Sklansky’s primary clinical and academic interests are in the field of prenatal detection and diagnosis of congenital heart disease. Following his early pioneering work in the field of 3D fetal echocardiography, Dr. Sklansky has since focused more generally on advancing the field of fetal cardiac imaging around the world.
Associate Professor of Cardiology, Director of Cardiology Fellowship Program, University of Siena, Siena, Italy
Scientific Activity: 175 Original articles on indexed Journals;
264 Personal Presentations at Congresses;24 Chairperson invitationsat International Congresses
EACVI elected Executilve Board Member
Elected EACVI Secretary for 2020-2022
After 15 years working at the Royal Brompton Hospital, London, the UK with the last 5 years holding the position Consultant in Cardiology/Echocardiography and Clinical Senior Lecturer at Imperial College London, Michael Henein accepted the position Professor of Cardiology at Umea University, Sweden in January 2010. He published over 350 papers, wrote 4 books, supervised 20 Ph.D. and 60 MSc theses. He is currently heading an active research program on arterial calcification, valve disease, and heart failure.
Currently a Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic. His main interests include preventive cardiology, clinical lipidology, CVD risk reduction strategies with special focus on very high-risk group (e.g. type 2 diabetes), and genetics of lipoprotein metabolism disorders.
He is the chairman of the Czech Atherosclerosis Society, member of board of the Czech Society of Internal Medicine and the chairman of the Czech Association of Preventive Cardiology of the Czech Society of Cardiology.
Milad El Segaier
Consultant Interventional Pediatric Cardiologist
King Fahad Medical City, Riyadh
Was the first female interventional cardiologist in the Gulf region and represented women on multiple committees including the Saudi Arabian Cardiac Interventional Society Board, Saudi Commission for Health Specialties Verification Committee, Saudi Commission for Health Specialties Cardiology Fellowship Committee as well as numerous international societies such a SCAI, ACC, and EAPCI.
Dr. Jeilan is Director of Cardiology at the Aga Khan University Hospital, Nairobi, and an interventional cardiologist with broad expertise in Coronary Angioplasty and Stent procedures; Pacemaker and Defibrillator therapy including Cardiac Resynchronisation Therapy; and valve interventions including TAVI. He has a particular interest in STEMI care and is a founder of the STEMI Africa initiative.
- EACVI HIT Committee Member
- Cardiovascular Medicine
- Cardiovascular Imaging
- Main interest in Interventional Echocardiography, Cross-Modality and Multimodality Imaging (Echo-CCT-CMR-SPECT), and Vascular Ultrasound
- More than 20 published papers in international peer-reviewed journals (Circulation Cardiovascular Imaging, International Journal of Cardiovascular Imaging, Echocardiography...) and book chapters
- Peer-reviewer in many journals
- Associate Editor, BMC Cardiovascular Disorders
Consultant interventional cardiologist Ex-head of cardiology 2012-2018, Kuwait Heart Center Chest Diseases Hospital, Kuwait.
Mohammad Almutairi is a Consultant Interventional Cardiologist and Ex-Chairman of the Department of Cardiology in Chest Diseases Hospital. He obtained his MB, ChB with honor from Kuwait medical school, Kuwait University in 1997. He did his internship year in Farwaniya Hospital followed by a year serving as an assistant registrar in internal medicine.
He went to do an internal medicine residency program at McGill University in Montreal, Canada from 1999 to 2002. He then stayed at McGill University to complete a three years cardiology fellowship from 2002 to 2005 and one extra year of interventional fellowship mainly trained to be a specialist in catheterization via the radial approach.
Dr. Almutairi returned to Kuwait in July 2006 and immediately joined the Cardiology Department in Chest Diseases Hospital. Since his return, he made sure to establish the radial approach as the preferred approach for catheterization in Kuwait and now more than 85% of cases are done radially. He also completed level II training in multislice cardiac CT.
Dr. Almutairi has served as a speaker and/or panelist in several international meetings.
Dr. Almutairi is a member of Kuwait Cardiac Society, a fellow of the Gulf Heart Association,
a fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC), a fellow of the American College of Cardiology (FACC), a fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI).
Dr. Almutairi served as the president of Kuwait Medical Association 2014-2018, the president of Arab medical Medical union 2017-2018 and the president of Gulf Intervention Society 2017-2019."
Dr. Kurdi is currently the president of the Saudi Arabian intervention cardiology society and senior interventional cardiology with a long history of involvement in government and private health care development he is currently the CMO of Clemenceau Medical Centre RIYADH and Head of cardiac services
United States of America
Professor of Medicine and Surgery and was the Director of Clinical Cardiac Electrophysiology at the University of Pittsburgh, Pennsylvania. He is formerly the attending physician at the Department of Cardiovascular Services at O’Connor Hospital in San Jose, California and served on the chair of quality control as well as advisory board in the department of cardiology. He is the founder of the Heart and Rhythm Medical Group. He is a fellow of the American College of Cardiology, American Heart Association, European Society of Cardiology, and the Heart rhythm Society. He has served as a chairperson and lecturer of many societies on topics related to arrhythmias, cardiac electrophysiology, and cardiac mapping and ablation. Dr Shenasa is a reviewer for many cardiology journals and has published extensively in a variety of subjects related to heart rhythm disorders. He is also an associate editor for Journal of Electrocardiography, and is on the editorial board for PACE (Pacing and Cardiac Electrophysiology) and is an associate editor for the section on “Basic Electrophysiology for the Clinician”. He is currently a fellow of the American College of Physicians, American College of Cardiology, American Heart Association, European Society of Cardiology, and the Heart Rhythm Society.
United Arab Emirates
Head of cardiology department and cath lab at mediclinic Airport Road hospital, Abu Dhabi, UAE,
intersent in complex coronary intervention, chronic total occlusion and rotablation atherectomy
Senior Consultant, Adult Interventional Cardiology, King Abdulaziz Medical City
Director of Cath Lab KACC
Associate Prof. KSAHSU National Guard Cardiac Sciences
Mohammed Omar Galal
Consultant Pediatric Cardiology
Since June 2016 till to date working at King Faisal Specialist Hospital & RC, Jeddah,.KSA.
2002 - Founder of PanArab Congenital Heart Disease Association."
United States of America
Distinguished Professor of Medicine And Cardiovascular Disease
President, International Society of Cardiovascular Ultrasound
United States of America
Neil E Strickman, M.D. is an interventional cardiologist at Baylor St. Luke’s Medical Center and professor at the Texas Heart Institute with specialization in non-surgical treatment of Aortic Valve Stenosis, TAVR, Aortic Aneurysm, EVAR, TEVAR, Carotid artery blockages, Peripheral Vascular Disease (PVD)(CLI), Pacemaker, Heart Artery Stents (CAD). He is a full-time Interventional Cardiologist since 1982. He is a board-certified Diplomat in Internal Medicine and Cardiovascular Diseases
Nicolas Van Mieghem
Dr. Nicolas M. Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, USA and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology in the Thoraxcenter, Erasmus MC as a senior staff member in February 2010. He is the clinical director of interventional cardiology since 2014 and full professor September 1 2019. He is a Fellow of the European Society of Cardiology (FESC) and the American College of Cardiology.
Consultant of diabetes at Kuwait diabetic center
Director Cardiology & Cardiovascular Surgery Institute (ICyCC)
Chief Cardiología Intervencionista
Hospital Universitario Fundación Favaloro
Board of Director University & Favaloro Foundation
Ex-SCAI Board of Trustees
TCT International Board Member & Scientific Committee"
Ozge Ozden Tok
I am a Cardiologist in İstanbul, at Bahçelievler Memorial
Hospital and I am a cardiovascular MMI Specialist(Echo,3D echo
Interventional echo,CCT and CMR)
I am interested in structural heart diseases and cardiomyopathies.
I am currently EACVI HIT Committee Member
EACVI Web&Commucation Committee Member
ESC Communication Committee Member.
I was also the previous EACVI HIT Ambassador of Turkey for Cardiovascular Imaging..I was awarded the EACVI grant in 2018 and I did my CMR training at Bristol Heart İnstitute under the supervision of Dr. Chiara Bucciarelli-Ducci.
"Present Position and Address
• President Heart failure Association of the ESC
• Academician of Serbian Academy of Science and Arts
• Professor, Belgrade University School of Medicine
• Heart failure Department, University Medical Center Belgrade
• President, Heart Failure Society of Serbia
Education and positions
• 2011-President, Heart Failure Society of Serbia
• 2011-14-President, the Board for heart transplantation
• 2011-13-Director, Department of Cardiology, University Medical Centre, Belgrade, Serbia
• 2009-12-Deputy director for science, University Medical Centre, Belgrade, Serbia
• 2008-Board member, Heart failure Association of the ESC
• 1996-Full Professor, Belgrade University School of Medicine
• 1994-Head, Cardiology II, Dept. of Cardiology, University Institute for Cardiovascular Diseases, Belgrade, Serbian and Montenegro
• 1992-Associate Professor, Belgrade University School of Medicine
• 1992-94-Head, Outpatient Department of Invasive & Interventional Cardiology, University Institute for Cardiovascular Diseases, Belgrade, FRY
• 1986-1987, 1990-1991 - Visiting Assistant professor, Methodist Hospital and Baylor College of Medicine, Houston, USA
• 1985- Visiting physician, Kings College Hospital, London, UK
Post Graduate Degrees
• 1981 - M.Sc.
• 1982 - Specialist in Internal Medicine
• 1984 - Subspecialist in Cardiology
• 1990 - Ph.D.
European Society of Cardiology Activities
• President-elect Heart failure Association of the ESC
• Member of the HFA Board
• Member of the ESC Nominating Committee
• Member of the seven Task Force in charge of various ESC Guidelines (2000-2019)"
Head Department of Internal Medicine and Cardiology, University Hospital Brno and Medical Faculty of Masaryk University, Brno, Czech Republic
President of the Czech Association of Interventional Cardiology, Czech Society of Cardiology Executive Board member
Chair of the EAPCI and EuroPCR Stent for Life Initiative 2012–2016 and member of the EAPCI Executive Board 2014-2016. EuroPCR Programme Committee member.
Author/co-author of more than 100 peer-reviewed articles focused on the diagnosis, treatment and prognosis of patients with ACS treated by PCI, coronary imaging, functional revascularization, complex PCI optimization and structural heart disease interventions. Founder of the national Czech TAVI Registry.
United States of America
Ramesh Daggubati is a Professor of Medicine and associate chief of cardiology at West Virginia University. He is also the director of structural heart disease. He oversees the clinical operations of cardiology at Heart and Vascular Institute and its 14 outreach hospitals. He is the Co-Chair of SCAI International Committee.
Ramesh Daggubati's clinical interests are complex PCI and structural heart disease."
Robert C. Hendel
United States of America
Robert C. Hendel, M.D. is presently the Sidney W and Marilyn S. Lassen Chair in Cardiovascular Medicine and a Professor of Medicine and Radiology at the Tulane University School of Medicine. He also serves as the Chief of the Section of Cardiology and Director of the Tulane Heart and Vascular Institute.
Dr. Hendel has served at the national level as the President of the American Society of Nuclear Cardiology and as President of the Cardiovascular Council of the Society of Nuclear Medicine (SNM) and received the Hermann Blumgardt Award from the SNM for outstanding service in nuclear cardiology. He is presently serving a second three-year on the Board of Trustees was a member of the appropriate use criteria task force at the ACC and has pioneered the implementation and evaluation of appropriate use criteria. He has also chaired the ACC/AHA Task Force on Clinical Data Standards. He is a Fellow of the American College of Cardiology (FACC), the American Heart Association (FAHA), and a Master of the American Society of Nuclear Cardiology (MASNC).
United States of America
"Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With over 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.
His current research interests include brachytherapy for restenosis prevention bioabsorbable/ biodegradable stents, HDL therapy, intracoronary imaging, valvular heart disease and catheter-based treatment of renal denervation. Dr. Waksman has authored/co-authored more than 310 published manuscripts and over 230 abstracts. He is also the author/co-author of more than 20 book chapters and the editor/co-editor of six books in the field of cardiology. He serves as the Editor-in-Chief of the journal Cardiovascular Revascularization Medicine and is on the editorial boards of numerous prominent scientific journals such as the Journal of American College of Cardiology and the American Journal of Cardiology."
United States of America
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI; Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes; Professor of Medicine (Cardiology) and Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai is an internationally renowned interventional cardiologist, and clinical research expert in the field of cardiovascular disease. She has built a globally-respected academic research center focused on developing randomized clinical trials and has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored >1,000 peer-reviewed articles. She has been included for three consecutive years in Clarivate Analytics: “Most Cited Researchers – Top 1%” as well as “The World’s Most Influential Scientific Minds” (Thomson Reuters). Dr. Mehran is a current member of the American College of Cardiology (ACC) Board of Trustees. She is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation (CRF) and founded Women as One, dedicated to advancing opportunities for women in medicine. Dr. Mehran is a recipient of several awards including the 2016 American College of Cardiology Bernadine Healy Leadership in CV disease award, the 2018 Nanette Wenger Award from Women’s Heart for excellence in research and education, the 2
Salama Hussein Omar
"Worked in Critical Care Medicine Department; Cairo University Since 1986.
Works as a consultant of Cardiology & Critical Care Medicine at Erfan Hospital Since 2003
CARDIAC PACING, AICD AND ELECTROPHYSIOLOGY –
passed the European Accreditation Exam of Cardiac Pacing
CRITICAL CARE MEDICINE –
NUCLEAR CARDIOLOGY -
Attended advanced training at ""Cleveland Clinic Foundation"" at the Nuclear Medicine Department (1991)
Multislice Cardiac CT Angiography:
Hear Failure Clinic: Running EECP program.
Chairing The CPR Committee at Erfan Hospital"
United States of America
Prof. Salwa Elgebaly is the founder and President of the Biotech Nour Heart, Inc., Virginia, USA and also holds a faculty position at the Department of Surgery, University of Connecticut Faculty of Medicine, Farmington, Connecticut, USA. She has identified the potent inflammatory mediator, Nourin, which is rapidly released by reversible myocardial ischemia within five minutes. She is currently developing a Nourin test as an early diagnostic biomarker for unstable angina patients. Additionally, her research targets the development of a new therapy for patients with ischemic heart diseases (IHD). She is developing a combined therapy of the anti-inflammatory Cyclosporin H (Nourin specific competitive antagonist) and the anti-apoptotic Cyclocreatine (ATP preservation during ischemia) to protect ischemic patients from ischemia/reperfusion injury.
Senior Interventional Cardiologist
Head of IVUS Laboratory
Head of Coronary Care Unit Prince Salman Heart Center
Sanjeev K Agarwal
United Arab Emirates
Consultant interventional cardiologist in department of cardiology at Rashid hospital, Dubai. He graduated from GSVM Medical College, Kanpur, India in 1983. After earning his postgraduation in 1987, he moved on to complete his postdoctoral training in cardiology. He has been associate professor of cardiology at Sri Venkateswara Institute of Medical Sciences, Tirupati, India and a visiting consultant to Apollo Hospital, New Delhi. His areas of interest are interventional cardiology and cardiac CT. He completed level III training in cardiac CT from Harbour hospital, UCLA. He is Board Certified in cardiovascular CT and has accreditation by SCCT, USA. He is a fellow of American College of Cardiology. Dr Agarwal has made several presentations in international meetings like Euro PCR and TCT and published research articles in peer reviewed journals. He regularly participates as a course faculty in national and international meetings.
United Arab Emirates
cardiology specialist A and head of the cardiology department, Ibrahim Bin Hamad Obaidallah, Ras Al Khaimah, UAE.
Shakeel A Qureshi
Interventionist in paediatric and adult congenital heart disease
Dr. Shelley Zieroth joined the Section of Cardiology at St. Boniface Hospital in Winnipeg in July 2006. She is currently an Associate Professor in the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics.
She is involved in several heart failure clinical trials as a PI, is National Lead for EMPACT-MI, EMPULSE, DETERMINE and FINE-ARTS clinical trials and she is on the Steering Committee of PARAGLIDE. She is the Immediate Past President of the Canadian Heart Failure Society and on the Canadian Cardiovascular Society Primary Panels for both the Heart Failure and Heart Transplant Guidelines. She is also Co-Chair of Canada’s largest annual heart failure meeting, HF Update and Scientific Planning Committee Chair for the Canadian Cardiovascular Congress.
Dr. Zieroth is actively engaged in Social Media and promotes #cardiotwitter for its rapid access to clinical trial data, publications and free online access to medical education. It is through this engagement Dr. Zieroth has become recognized as a global supporter and sponsor of women in medicine and cardiology.
Head of Electrophysiology at the University of Giessen/Germany. He was a senior consultant and trained at Asklepios St. George Hospital in Hamburg.
Interventional and Structural Cardiologist.
Head of Cath Lab. Prince Sultan Cardiac Center (PSCC) Riyadh.
United States of America
Dr. King became the first director of the Cardiac Catheterization Laboratory of Emory University Hospital, was president of the American College of Cardiology (ACC) (1998–1999) president of SCAI (1991–1992), and he served as the first chair of the Interventional Cardiology Board of the American Board of Internal Medicine (1997–2007). Currently, he is chairman of the New York State Cardiac Advisory Board and has participated on many committees of the American Heart Association (AHA), ACC, and the National Heart, Lung, and Blood Institute (NHLBI).
Steffen Petersen is a Professor of Cardiovascular Medicine at the William Harvey Research Institute, Queen Mary University of London and a Consultant Cardiologist at Barts Heart Centre, Barts Health NHS Trust. He is also the Cardiovascular Programme Director of UCLPartners Academic Medical Centre. He is President-Elect of the European Society of Cardiology's (ESC) European Association of Cardiovascular Imaging (EACVI). He is the chief specialty editor of Frontiers in Cardiovascular Medicine’s Cardiovascular Imaging section. He holds an MBCHB and MDRES equivalent (Dr med.) from Johannes Gutenberg University Mainz, Germany, a DPHIL (OXON) from the Department of Cardiovascular Medicine, University of Oxford, an MPH from Harvard School of Public Health and an MSc in Health Economics, Outcomes and Management in Cardiovascular Science from the London School of Economics. He is level 3 certified for cardiovascular magnetic resonance (CMR). He has been actively involved in cardiovascular magnetic resonance since 1998 and he reports over 1000 cardiac adult MRI scans each year.
"Prof. Dr. med. Stephan Achenbach is the Chairman of the Department of Cardiology and Professor of Medicine at the University of Erlangen, Germany. His main clinical interests are Interventional Cardiology, General Cardiology as well as Cardiac Imaging. His research is focused on cardiac interventions and cardiac imaging a special focus on computed tomography of the heart and the use of imaging to support coronary and structural procedures
Stephan Achenbach was the Founding President of the Society of Cardiovascular Computed Tomography. He has been Editor-in-Chief of the Journal of Cardiovascular Computed Tomography. He has been on the Board of the European Society since 2012, serving as Councillor (2012-2014), Vice President (2014-2016), Chairman of the Congress Programme Committee (2016-2018) and President-Elect (2018-2020). He is the President of the European Society of Cardiology (ESC) for the mandate 2020 to 2022.
Stephan Achenbach has received several awards, including the Jan Brod Award for Clinical Research of the Medical School of Hannover, Germany (1999), the Thomas C. Cesario Distinguished Visiting Professorship Award, University of California Irvine School of Medicine (2007), the Simon Dack Award, American College of Cardiology (2009), the Gold Medal of the Society of Cardiovascular Computed Tomography (2015), and the Sir Godfrey Hounsfield Award of the British Institute of Radiology (2016), he was selected by AuntMinnie.com as the “Most Influential Radiology Researcher” in 2017, and he has repeatedly received the 1st Prize Best Teaching Award, Clinical Medicine, Medical Faculty of the University of Erlangen-Nürnberg (2013, 2014, 2016, 2017, 2018, 2019)."
Dr. Sundeep Mishra, MD, DM, FACC, FSCAI is Professor of Cardiology at AIIMS, New Delhi. He did his DM in Cardiology from AIIMS and did his Fellowship in Interventional Cardiology from Washington Hospital Center, USA. He has been Guest Editor of Catheterization and Cardiovascular Interventions Journal has been Past Editor-in-Chief of Indian Heart Journal, International Editor, Sri Lanka Journal of Cardiology and is on the Editorial Board of several journals. He was a Board of Trustees of SCAI, USA. He is the Course Director for TCT India, EuroCHORUS, SCAI Advanced Course and SIM. He is the Past Chairman of National Intervention Council of India and has organized several “India Sessions” on sidelines of several meetings; ACC, ESC, SCAI, TCT, CCT, EuroPCR, AsiaPCR, GulfPCR, IC-MED, K-Imaging, Italian Society of Cardiology, Turkish Society of Cardiology, and Egyptian Society of Cardiology, TCT-AP, CHORUS. He is the voting selector of the MSCAI Nominating Committee. He is Winner of Global Interventional Quiz, conducted by American Heart Association in New Orleans, November 2016 and National Cardiology Quiz at the Annual CSI Meeting 2013 at Bangalore. Recipient of the Best Academician Award by Tamil Nadu CSI, he was also awarded the “Young Leader Award” by Cardiovascular Revascularization Therapeutics (CRT), Washington DC, USA and has been awarded Sujoy B Roy “Young Investigator Award” and KL Chopra Award. He was the first person to do Virtual Histology, Experimental Angiogenic Gene Therapy in India and he developed the Rat Hind Limb Ischemia Model for the first time in India. He has more than 200 Manuscripts, Abstracts. His book (as Editor in Chief) Cath lab Practicals Manual is a best-seller among cardiology books and Recent Research & Analysis in Cardiology is another bestseller. Besides he has several book chapters to his credit in other books He is Winner of Global Interventional Quiz, conducted by American Heart Association in New Orleans, November 2016 and National Cardiology Quiz at the Annual CSI Meeting 2013 at Bangalore. He has delivered several orations and talks in prestigious meetings.
United States of America
Dr. Helmy is a Professor of cardiology and director of the J. Gerard Mudd Cardiac Catheterization Lab at Saint Louis University School of Medicine, St. Louis Missouri.
Dr. Helmy is a 1991 graduate of Cairo University, Egypt. In June 2000, he completed his Cardiology Fellowship at the University of Texas Medical Branch in Galveston, Texas. He completed his Interventional Cardiology Fellowship at New England Medical Center Tufts University, Boston, Massachusetts. He has served as an Assistant Professor of Medicine at Emory University School of Medicine, Atlanta, Georgia, and Professor of Medicine, Director of the interventional cardiology fellowship program, and director of the cardiac Catheterization Lab at the University Of Cincinnati, Ohio. Currently, Dr. Helmy is a Professor of cardiology and director of the J. Gerard Mudd Cardiac Catheterization Lab at Saint Louis University School of Medicine, St. Louis Missouri.
Dr. Helmy has published over 100 articles and abstracts and has lectured over 60 times across the United States and worldwide. He has been involved in Clinical Teaching of general and interventional cardiology fellows since 2002 to the present.
Dr. Helmy has published several peer-reviewed articles and has lectured both nationally and internationally. He has been involved in Clinical Teaching of general and interventional cardiology fellows since 2002."
"Dr. Thomas Alexander M.D., D.M., F.A.C.C. currently holds the position of a Consultant and Interventional Cardiologist and Head of Division of Cardiology at Kovai Medical Center and Hospital, Coimbatore.
Dr. Thomas Alexander did his undergraduate, post graduate and super-specialty training in Cardiology from the Christian Medical College, Vellore. He worked as a Lecturer in Cardiology in Christian Medical College, Vellore from 1989 to 1991 and as a Fellow in Cardiology at the Epworth Hospital, Melbourne, Australia from 1991 to 1993.
From May 1993, he has been working at the Kovai Medical Center and Hospital, Coimbatore initially as a Consultant and then as the Head of the division of Cardiology. Kovai Medical Center and Hospital is a 900 bed tertiary care centre in Coimbatore, Tamilnadu. During this period, he had been able to establish a very active interventional unit in that hospital and one of the leading STEMI centres in the country. The department performs approximately 3500 procedures a year which includes over 1500 cardiac interventions including approximately 700 primary PCI procedures each year.
He is the program director for training of candidates towards Dip. NB in Cardiology, which is a higher speciality training program in Cardiology conducted by the National Board of Medical Sciences. He has published over 60 papers in various National and International journals and is a faculty at many National and International workshops and meetings including leading International meetings of the American College of Cardiology, American Heart Association, TCT and Euro PCR.
Dr. Thomas Alexander has established STEMI INDIA, a not for profit organisation' along with Dr. Ajit Mullasari. He is the Course Director of the STEMI INDIA meeting which is an international meeting focused on STEMI care. Dr. Alexander has been recognised as a pioneer in research in developing STEMI systems of care. His initial work in the Tamilnadu STEMI program resulted in this program being adopted by the National Health Mission with similar programs being initiated in other Indian states. STEMI India is assisting other countries to implement similar programs which is currently acknowledged as the Global STEMI Model for Low and Middle-Income countries.
He is a fellow of the American College of Cardiology, Indian College of Cardiology and the Cardiological Society of India."
Head of the Cathlab in University Hospital in Marseille. Involved in both coronary and structural interventions and many publications on DAPT. Part of PCR activities as PCM of EuroPCR, COurse Director Gulf PCR and Medical Director of PCR Webinar Activities.
"Professor Lüscher is Director of Research, Education & Development and Consulting Cardiologist at the Royal Brompton & Harefield Hospital Trust and Professor of Cardiology at the National Heart and Lung Institute of the Imperial College in London.
His research is translational and focuses on atherosclerosis as well as acute coronary syndromes He has published extensively and has been rated as one of the most cited scientists worldwide. He is editor of the ESC Textbook of Cardiovascular Medicine, Oxford University Press and was editor-in-chief of the European Heart Journal 2009-2020. He is now secretary/treasurer of the European Society of Cardiology."
Department of Cardiac Surgery, University Medical Centre Maribor, Slovenia
Department of Cardiology, University Medical Centre Ljubljana, Slovenia
Role in the ESC/EACVI:
ESC Clinical Case Gallery Task Force Member
EACVI Scientific Initiatives and Heart Imagers of Tomorrow Committee Member 2020-2022
EACVI HIT National Ambassador of Slovenia for CMR
Tugba Kemaloglu Oz
Im the coordinator and co-founder of IYAC and the head of echo laboratory of LİV hospital ulus. Additionally, I work as an editor in many important scientific journals such as Echocardiography, Minerva Cardiology and Angiology, IJCVA etc
1990 – 1991 General Practitioner-Kostenetz
1991 – 2001 Cardiologist in Emergency Hospital Pirogov- Sofia, Bulgaria
August 2001 – 2009 National Heart Center – Interventional cardiologist- Cath Lab Sofia, Bulgaria
April 2009 – March 2013 - Head of Interventional Cardiology Department - University Emergency Hospital “ N.I. Pirogov” Sofia, Bulgaria
From March 2013 till now - Director of Cardiology Clinic -Tokuda Hospital Sofia, Bulgaria
Working as a consultant cardiologist in University Hospital Centre Zagreb, Croatia, Department of Cardiovascular Diseases. Main focus of interest: echocardiography and valvular heart disease. Secretary of the Working Group of Echocardiography and imaging modalities, Croatian Cardiac Society. Heart Imagers of Tomorrow ambassador for Croatia and EACVI HIT Committee member.
United States of America
Ziad Ali is the Victoria and Esther Aboodi Cardiology Researcher, Louis V Gerstner Jr Scholar, Assistant Professor of Medicine at Columbia University Medical Center (CUMC) where he serves as the Director of Intravascular Imaging and Physiology and Director of the Cardio-renal program. He is also the Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation.
His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound and flow wire assessment to optimize coronary interventions. Dr. Ali is the Global PI of the International Multicenter Randomized Controlled Trials ILUMIEN III and IV, a comparison of optical coherence tomography to angiography to guide PCI and improve clinical outcomes. Dr. Ali pioneered techniques to perform diagnostic angiography with ultra-low contrast volumes and perform interventions without contrast administration, protecting patients with advanced kidney disease from need for dialysis.
earned his MD at the American University of Beirut (AUB) Faculty of Medicine and completed his residency in internal medicine at AUB Medical Center in 1984. Dr. Ghazzal has upheld an academic rigor in all his professional life, becoming an internationally renowned interventional cardiologist who has excelled as a highly accomplished clinician, researcher, and teacher/ mentor. He was promoted to professor of medicine at Emory University, Atlanta, GA, where he has been a full-time faculty member since 1990